Get started
Author

Anne Dekeyne

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways
2003 · M.J. Millan, A. Gobert, et al. · Journal of Pharmacology and Experimental Therapeutics · 537
Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo
1998 · M.J Millan, A Dekeyne, et al. · Neuropharmacology · 290
Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade
2004 · Mark J. Millan, Mauricette Brocco, et al. · Psychopharmacology · 253
Agonist and antagonist actions of yohimbine as compared to fluparoxan at ?2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states
2000 · Mark J. Millan, Adrian Newman-Tancredi, et al. · Synapse · 196
5‐HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia
2012 · Julie Meffre, Séverine Chaumont‐Dubel, et al. · EMBO Molecular Medicine · 185
PDF
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α2‐adrenergic and serotonin2C receptors: a comparison with citalopram
2000 · M. J. Millan, A. Gobert, et al. · European Journal of Neuroscience · 175
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
2008 · Anne Dekeyne, Clotilde Mannoury la Cour, et al. · Psychopharmacology · 131
A Comparative In Vitro and In Vivo Pharmacological Characterization of the Novel Dopamine D3Receptor Antagonists (+)-S 14297, Nafadotride, GR 103,691 and U 99194
1998 · Valérie Audinot, Adrian Newman-Tancredi, et al. · Journal of Pharmacology and Experimental Therapeutics · 128
Selective blockade of dopamine D3versus D2receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis
2006 · Mark J. Millan, Benjamin Di Cara, et al. · Journal of Neurochemistry · 127
S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: II. Behavioral Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine
2001 · Mark J. Millan, Anne Dekeyne, et al. · Journal of Pharmacology and Experimental Therapeutics · 119
S33084, a Novel, Potent, Selective, and Competitive Antagonist at Dopamine D3-Receptors: II. Functional and Behavioral Profile Compared with GR218,231 and L741,626
2000 · Mark J. Millan, Anne Dekeyne, et al. · Journal of Pharmacology and Experimental Therapeutics · 119
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake
2002 · Mauricette Brocco, Anne Dekeyne, et al. · Pharmacology Biochemistry and Behavior · 111
Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex
2007 · Florence Loiseau, Anne Dekeyne, et al. · Psychopharmacology · 109
Citalopram reduces social interaction in rats by activation of serotonin (5-HT)2C receptors
2000 · A Dekeyne, B Denorme, et al. · Neuropharmacology · 97
S18616, a Highly Potent Spiroimidazoline Agonist at α2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
2000 · Mark J. Millan, Françoise Lejeune, et al. · Journal of Pharmacology and Experimental Therapeutics · 89
S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
1998 · Mark J. Millan, Rudy Schreiber, et al. · Journal of Pharmacology and Experimental Therapeutics · 87
S33138 (N-[4-[2-[(3 aS,9 bR)-8-cyano-1,3 a,4,9 b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3 H)-yl)-ethyl]phenyl-acetamide), a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent: III. Actions in Models of Therapeutic Activity and Induction of Side Effects
2007 · Mark J. Millan, Florence Loiseau, et al. · Journal of Pharmacology and Experimental Therapeutics · 79
S 18126 ({2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl}), a Potent, Selective and Competitive Antagonist at Dopamine D4 Receptors: An In Vitro and In Vivo Comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2,3b]pyridine) and Raclopride
1998 · Mark J. Millan, Adrian Newman-Tancredi, et al. · Journal of Pharmacology and Experimental Therapeutics · 74
The Serotonin1A Receptor Partial Agonist S15535 [4-(Benzodioxan-5-yl)1-(indan-2-yl)piperazine] Enhances Cholinergic Transmission and Cognitive Function in Rodents: A Combined Neurochemical and Behavioral Analysis
2004 · Mark J. Millan, Alain Gobert, et al. · Journal of Pharmacology and Experimental Therapeutics · 71
S18616, a Highly Potent, Spiroimidazoline Agonist at α2-Adrenoceptors: I. Receptor Profile, Antinociceptive and Hypothermic Actions in Comparison with Dexmedetomidine and Clonidine
2000 · Mark J. Millan, Anne Dekeyne, et al. · Journal of Pharmacology and Experimental Therapeutics · 63
Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats
2006 · Benjamin Di Cara, Fany Panayi, et al. · The International Journal of Neuropsychopharmacology · 62
PDF
The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats
2000 · A. Dekeyne, M. Brocco, et al. · Psychopharmacology · 62
Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO60-0175: a pharmacological analysis
1999 · A. Dekeyne, S. Girardon, et al. · Neuropharmacology · 61
S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: III. Actions in Models of Potential Antidepressive and Anxiolytic Activity in Comparison with Ropinirole
2004 · Mark J. Millan, Mauricette Brocco, et al. · Journal of Pharmacology and Experimental Therapeutics · 53
Differential effects of several retrieval cues over time: Evidence for time-dependent reorganization of memory
1989 · Pascale Gisquet-Verrier, Anne Dekeyne, et al. · Animal Learning & Behavior · 53
PDF
Works count: 95
Citation count: 4,365
H-index: 36
I10-index: 61
Year
Topic
Type